Fogarty International Center Notice of Meeting, 428-429 [2019-00211]
Download as PDF
<![CDATA[
428
Federal Register / Vol. 84, No. 18 / Monday, January 28, 2019 / Notices
identified by Docket No. CDC–201x–
xxxx using the Federal eRulemaking
Portal: https://www.regulations.gov.
Follow the instructions for submitting
comments. All submissions received
must include the agency name and
Docket Number. All relevant comments
received in conformance with the
regulations.gov suitability policy will be
posted without change to https://
regulations.gov, including any personal
information provided. For access to the
docket to read background documents
or comments received, go to https://
www.regulations.gov. Written public
comments submitted by 72 hours prior
to the ACIP meeting will be provided to
the ACIP members before the meeting.
Matters to be Considered: The agenda
will include discussions on human
papillomavirus vaccines, pneumococcal
vaccines, Japanese encephalitis
vaccines, influenza vaccines, anthrax
vaccine, hepatitis vaccines, Pertussis
vaccine, herpes zoster vaccine, and
meningococcal vaccines. A
recommendation vote is scheduled for
anthrax vaccine, Japanese encephalitis
vaccines, and human papillomavirus
vaccines. Agenda items are subject to
change as priorities dictate. For more
information on the meeting agenda visit
https://www.cdc.gov/vaccines/acip/
meetings/meetings-info.html.
The Chief Operating Officer, Centers
for Disease Control and Prevention, has
been delegated the authority to sign
Federal Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Sherri A. Berger,
Chief Operating Officer, Centers for Disease
Control and Prevention.
[FR Doc. 2019–00197 Filed 1–25–19; 8:45 am]
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
amozie on DSK3GDR082PROD with NOTICES1
Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended, and the Determination of
the Chief Operating Officer, CDC,
pursuant to Public Law 92–463. The
16:01 Jan 25, 2019
Jkt 247001
discussions could disclose confidential
trade secrets or commercial property
such as patentable material, and
personal information concerning
individuals associated with the grant
applications and/or contract proposals,
the disclosure of which would
constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Disease, Disability,
and Injury Prevention and Control Special
Emphasis Panel; (SEP)—PAR 15–303,
Occupational Safety and Health Education
and Research Centers (ERC).
Dates and Times: February 11, 2019, 6:00
p.m.–8:00 p.m. EST, February 12–13, 2019,
8:30 a.m.–5:00 p.m. EST.
Place: Hilton Alexandria Old Town, 1767
King Street, Alexandria, Virginia 22314,
(703)837–0440.
Agenda: To review and evaluate grant
applications.
For Further Information Contact: Michael
Goldcamp, Ph.D., Scientific Review Officer,
Office of Extramural Programs, CDC, 1095
Willowdale Road, Morgantown, West
Virginia 26505, (304) 285–5951;
mgoldcamp@cdc.gov.
The Chief Operating Officer, Centers for
Disease Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for both
the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Name of Committee: Fogarty International
Center Advisory Board.
Date: February 11–12, 2019.
Closed: February 11, 2019, 1:00 p.m. to
5:00 p.m.
Agenda: Second level review of grant
applications.
Place: National Institutes of Health,
Lawton L. Chiles International House,
Building 16, Conference Room, 16 Center
Drive, Bethesda, MD 20892.
Open: February 12, 2019, 9:00 a.m. to 3:00
p.m.
Agenda: Update and discussion of current
and planned FIC activities.
Place: National Institutes of Health,
Lawton L. Chiles International House,
Building 16, Conference Room, 16 Center
Drive, Bethesda, MD 20892.
Contact Person: Kristen Weymouth,
Executive Secretary, Fogarty International
Center, National Institutes of Health, 31
Center Drive, Room B2C02, Bethesda, MD
20892, (301) 496–1415, weymouthk@
mail.nih.gov.
This meeting notice is being published less
than 15 days in advance of the meeting due
to the partial Government shutdown of
December 2018.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has
instituted stringent procedures for entrance
onto the NIH campus. All visitor vehicles,
including taxicabs, hotel, and airport shuttles
will be inspected before being allowed on
campus. Visitors will be asked to show one
form of identification (for example, a
government-issued photo ID, driver’s license,
or passport) and to state the purpose of their
visit.
Information is also available on the
Institute’s/Center’s home page: https://
www.fic.nih.gov/About/Advisory/Pages/
default.aspx, where an agenda and any
additional information for the meeting will
be posted when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.106, Minority International
Research Training Grant in the Biomedical
and Behavioral Sciences; 93.154, Special
International Postdoctoral Research Program
in Acquired Immunodeficiency Syndrome;
93.168, International Cooperative
Biodiversity Groups Program; 93.934, Fogarty
International Research Collaboration Award;
93.989, Senior International Fellowship
Awards Program, National Institutes of
Health, HHS)
Sherri Berger,
Chief Operating Officer, Centers for Disease
Control and Prevention.
[FR Doc. 2019–00198 Filed 1–25–19; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Fogarty International Center Notice of
Meeting
BILLING CODE 4163–18–P
VerDate Sep<11>2014
grant applications and the discussions
could disclose confidential trade secrets
or commercial property such as
patentable material, and personal
information concerning individuals
associated with the grant applications,
the disclosure of which would
constitute a clearly unwarranted
invasion of privacy.
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
meeting of the Fogarty International
Center Advisory Board. The meeting
will be open to the public as indicated
below, with attendance limited to space
available. Individuals who plan to
attend and need special assistance, such
as sign language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications
and/or contract proposals and the
PO 00000
Frm 00018
Fmt 4703
Sfmt 4703
E:\FR\FM\28JAN1.SGM
28JAN1
Federal Register / Vol. 84, No. 18 / Monday, January 28, 2019 / Notices
Dated: January 22, 2019.
Natasha M. Copeland,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2019–00211 Filed 1–25–19; 8:45 am]
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review Notice of
Closed Meeting
amozie on DSK3GDR082PROD with NOTICES1
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Surgical Sciences,
Biomedical Imaging and Bioengineering
Integrated Review Group; Bioengineering,
Technology and Surgical Sciences Study
Section.
Date: February 11–12, 2019.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hyatt Regency Bethesda, One
Bethesda Metro Center, 7400 Wisconsin
Avenue, Bethesda, MD 20814.
Contact Person: Khalid Masood, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5120,
MSC 7854, Bethesda, MD 20892, 301–435–
2392, masoodk@csr.nih.gov.
This meeting notice is being published less
than 15 days in advance of the meeting due
to the partial Government shutdown of
December 2018.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research; 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: January 22, 2019.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
BILLING CODE 4140–01–P
VerDate Sep<11>2014
16:01 Jan 25, 2019
Jkt 247001
National Institutes of Health
Center for Scientific Review Notice of
Closed Meeting
BILLING CODE 4140–01–P
[FR Doc. 2019–00210 Filed 1–25–19; 8:45 am]
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Musculoskeletal, Oral
and Skin Sciences Integrated Review Group;
Musculoskeletal Tissue Engineering Study
Section.
Date: February 11–12, 2019.
Time: 8:00 a.m. to 2:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Virginian Suites, 1500 Arlington
Boulevard, Arlington, VA 22209.
Contact Person: Baljit S. Moonga, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4214,
MSC 7806, Bethesda, MD 20892, 301–435–
1777,moongabs@mail.nih.gov.
This meeting notice is being published less
than 15 days in advance of the meeting due
to the partial Government shutdown of
December 2018.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research; 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: January 22, 2019.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2019–00216 Filed 1–25–19; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Nursing Research
Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
PO 00000
Frm 00019
Fmt 4703
Sfmt 4703
429
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Nursing Research Special Emphasis Panel;
Fellowship Applications.
Date: February 6, 2019.
Time: 11:00 a.m. to 1:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, One
Democracy Plaza 703, 6701 Democracy
Boulevard, Bethesda, MD 20892 (Telephone
Conference Call).
Contact Person: Tamizchelvi Thyagarajan,
Ph.D., Scientific Review Officer, National
Institute of Nursing Research, National
Institutes of Health, Bethesda, MD 20892,
(301) 594–0343, tamizchelvi.thyagarajan@
nih.gov.
This meeting notice is being published less
than 15 days in advance of the meeting due
to the partial Government shutdown of
December 2018.
(Catalogue of Federal Domestic Assistance
Program No. 93.361, Nursing Research,
National Institutes of Health, HHS)
Dated: January 22, 2019.
Sylvia L. Neal,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2019–00213 Filed 1–25–19; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Cancer Institute Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
E:\FR\FM\28JAN1.SGM
28JAN1
]]>Agencies
[Federal Register Volume 84, Number 18 (Monday, January 28, 2019)]
[Notices]
[Pages 428-429]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-00211]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Fogarty International Center Notice of Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of a meeting of the Fogarty
International Center Advisory Board. The meeting will be open to the
public as indicated below, with attendance limited to space available.
Individuals who plan to attend and need special assistance, such as
sign language interpretation or other reasonable accommodations, should
notify the Contact Person listed below in advance of the meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and/or contract proposals
and the discussions could disclose confidential trade secrets or
commercial property such as patentable material, and personal
information concerning individuals associated with the grant
applications and/or contract proposals, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: Fogarty International Center Advisory Board.
Date: February 11-12, 2019.
Closed: February 11, 2019, 1:00 p.m. to 5:00 p.m.
Agenda: Second level review of grant applications.
Place: National Institutes of Health, Lawton L. Chiles
International House, Building 16, Conference Room, 16 Center Drive,
Bethesda, MD 20892.
Open: February 12, 2019, 9:00 a.m. to 3:00 p.m.
Agenda: Update and discussion of current and planned FIC
activities.
Place: National Institutes of Health, Lawton L. Chiles
International House, Building 16, Conference Room, 16 Center Drive,
Bethesda, MD 20892.
Contact Person: Kristen Weymouth, Executive Secretary, Fogarty
International Center, National Institutes of Health, 31 Center
Drive, Room B2C02, Bethesda, MD 20892, (301) 496-1415,
weymouthk@mail.nih.gov.
This meeting notice is being published less than 15 days in
advance of the meeting due to the partial Government shutdown of
December 2018.
Any interested person may file written comments with the
committee by forwarding the statement to the Contact Person listed
on this notice. The statement should include the name, address,
telephone number and when applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has instituted stringent
procedures for entrance onto the NIH campus. All visitor vehicles,
including taxicabs, hotel, and airport shuttles will be inspected
before being allowed on campus. Visitors will be asked to show one
form of identification (for example, a government-issued photo ID,
driver's license, or passport) and to state the purpose of their
visit.
Information is also available on the Institute's/Center's home
page: https://www.fic.nih.gov/About/Advisory/Pages/default.aspx,
where an agenda and any additional information for the meeting will
be posted when available.
(Catalogue of Federal Domestic Assistance Program Nos. 93.106,
Minority International Research Training Grant in the Biomedical and
Behavioral Sciences; 93.154, Special International Postdoctoral
Research Program in Acquired Immunodeficiency Syndrome; 93.168,
International Cooperative Biodiversity Groups Program; 93.934,
Fogarty International Research Collaboration Award; 93.989, Senior
International Fellowship Awards Program, National Institutes of
Health, HHS)
[[Page 429]]
Dated: January 22, 2019.
Natasha M. Copeland,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2019-00211 Filed 1-25-19; 8:45 am]
BILLING CODE 4140-01-P
